Skip to main content


PharmaFluidics  is a microfluidics company founded in 2012 and offers integrated milli- to nano-solutions for mixing, reaction and separation, with a focus on pharmaceutical processes and specialty chemistry. It is the aim of PharmaFluidics to facilitate the adoption of microfluidics in biotechnological and pharmaceutical processes. The company offers tailored solutions for processes that benefit from its unique expertise in micro- and nano-structured devices for the control of laminar flows, in a technology-independent fashion.

PharmaFluidics BVBA was founded in 2011 as a spin-off of the Department of Chemical Engineering (CHIS) at the VUB by Dr. ir. Wim De Malsche, Prof. Dr. ir. Gert Desmet, Prof. Dr. ir. Joeri Denayer and Dr. ir. Paul Jacobs. The company represents a unique combination of know-how, and has access to state-of-the-art clean rooms and micromachining capabilities that enable it to provide its clients with innovative products and novel concepts. During the last decade, the department of Chemical Engineering has played a pioneering role in the development of miniaturized devices for analytical and general chemical engineering applications.

PharmaFluidics became part of Thermo Fisher Scientific in November 2021.



2011: PharmaFluidics established
2012: first contract development agreement with large pharma company
2013: demonstration of sub-micron plate heights implementing a novel support structure format for HPLC
2013: development of generic ultra-stable membrane contactor

2017: µPAC™ honoured in The Analytical Scientist Innovation Awards 2017
2018: PharmaFluidics raises 7.3 million euro
2019: introduction µPAC™ trapping column
2020: receives VLAIO grant of €613.000
2021: acquired by Thermo Fisher Scientific 



Johan Devenyns, Managing Director

Technologiepark-Zwijnaarde 82
B-9052 Ghent

[T] +32 (0)9 241 56 57